Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,4.394177254412854e-36,22.256874797800066,1811.9941189400802,"['RPL30', 'RPL32', 'RPL34', 'RPL10A', 'RPL8', 'RPL9', 'RPL7', 'RPS15', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24']",8.612587418649195e-34,0,0,56
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.2750332514214468e-23,21.058376839107737,1097.9303321398374,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5']",2.229532586393018e-21,0,0,36
3,Nonalcoholic fatty liver disease WP4396,3.307058331162158e-19,14.84155701754386,631.5536320415058,"['NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'CYCS']",2.160611443025943e-17,0,0,33
4,Mitochondrial CIV Assembly WP4922,6.4845636510545746e-12,38.4472049689441,990.4613842809588,"['COX8A', 'COA3', 'COX7B', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",3.1774361890167416e-10,0,0,15
5,Mitochondrial complex I assembly model OXPHOS system WP4324,8.592458293855071e-10,16.45075421472937,343.40893579509196,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",3.368243651191188e-08,0,0,15
6,Oxidative phosphorylation WP623,9.950988326751419e-09,10.247144340602285,188.80972088366232,"['ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA4', 'NDUFA2', 'NDUFB2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",3.2506561867387964e-07,0,0,16
7,Pyrimidine metabolism WP4022,1.1783202100619779e-05,11.309451219512194,128.3491025203179,"['POLD2', 'POLE3', 'NME2', 'POLR2I', 'DCK', 'DCTPP1', 'POLR2J', 'POLR2K', 'POLR2L']",0.0003299296588173538,0,0,9
8,Mitochondrial complex III assembly WP4921,0.0019942209568882202,9.318524096385541,57.937940367825426,"['UQCRB', 'UQCRQ', 'UQCR11', 'UQCR10', 'UQCRH']",0.048016451018380105,0,0,5
9,Selenium Micronutrient Network WP15,0.00220483703655827,5.237272727272727,32.03692979410006,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH']",0.048016451018380105,0,0,7
10,VEGFA-VEGFR2 Signaling Pathway WP3888,0.010236076430598012,1.9420852543880935,8.89831786959656,"['SET', 'SDF2L1', 'CRIP2', 'TXN', 'RPL10A', 'NDRG1', 'RPL7', 'DNAJA1', 'RPL18A', 'TMSB4X', 'AP2S1', 'PGK1', 'CYCS', 'RPLP2', 'RPL27', 'RPL26', 'TMSB10', 'PTMA', 'HRAS', 'ARF6']",0.20062709803972106,0,0,20
11,Hippo-Yap signaling pathway WP4537,0.0142841496184539,inf,inf,"['YWHAQ', 'NDRG1']",0.254517575019724,0,0,2
12,DNA Repair Pathways Full Network WP4946,0.023490156598737065,4.950950950950951,18.571877560222482,"['NEIL2', 'CENPX', 'POLD2', 'POLE3']",0.35415928410403574,0,0,4
13,Non-small cell lung cancer WP4255,0.023490156598737065,4.950950950950951,18.571877560222482,"['GADD45B', 'BAD', 'CYCS', 'HRAS']",0.35415928410403574,0,0,4
14,Base Excision Repair WP4752,0.025756596709017244,7.413173652694611,27.125280558307008,"['NEIL2', 'POLD2', 'POLE3']",0.3605923539262414,0,0,3
15,DNA Mismatch Repair WP531,0.03945157416790979,14.794029850746268,47.824384088411335,"['POLD2', 'POLE3']",0.47428656333722025,0,0,2
16,Nucleotide metabolism WP404,0.03945157416790979,14.794029850746268,47.824384088411335,"['NME2', 'OAZ1']",0.47428656333722025,0,0,2
17,IL-3 signaling pathway WP286,0.04113709988128951,5.557634730538922,17.733550386728904,"['YWHAQ', 'BAD', 'HRAS']",0.47428656333722025,0,0,3
18,Copper homeostasis WP3286,0.06010950541459492,4.444311377245509,12.495569380933983,"['COX17', 'MT3', 'ATOX1']",0.6195899024427791,0,0,3
19,MET in type 1 papillary renal cell carcinoma WP4205,0.06010950541459492,4.444311377245509,12.495569380933983,"['BAD', 'RPL11', 'HRAS']",0.6195899024427791,0,0,3
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.07270697834787714,7.394029850746269,19.38210288053165,"['COX8A', 'COX5A']",0.6195899024427791,0,0,2
21,Cellular Proteostasis WP4918,0.07270697834787714,7.394029850746269,19.38210288053165,"['PFDN2', 'PFDN5']",0.6195899024427791,0,0,2
22,Nucleotide Excision Repair WP4753,0.07270697834787714,7.394029850746269,19.38210288053165,"['POLD2', 'POLE3']",0.6195899024427791,0,0,2
23,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.07270697834787714,7.394029850746269,19.38210288053165,"['BAD', 'HRAS']",0.6195899024427791,0,0,2
24,Synaptic Vesicle Pathway WP2267,0.07624471861459009,2.9657657657657657,7.6333090737323515,"['AP2S1', 'PARK7', 'AP2M1', 'VAMP2']",0.621147669608831,0,0,4
25,EGF/EGFR signaling pathway WP437,0.08136776354216894,2.228700906344411,5.5913115894876455,"['NDUFA13', 'AP2S1', 'NEDD8', 'HRAS', 'AP2M1', 'ARF6']",0.621147669608831,0,0,6
26,Eukaryotic Transcription Initiation WP405,0.08239713984606943,3.7020958083832336,9.241188413546858,"['POLR2I', 'POLR2J', 'POLR2K']",0.621147669608831,0,0,3
27,mRNA Processing WP411,0.09456722779231849,2.695058695058695,6.356145796509087,"['SRSF3', 'SNRPE', 'HNRNPA1', 'SRSF9']",0.6864880239738675,0,0,4
28,Cardiac Progenitor Differentiation WP2406,0.11176515396660434,4.927363184079602,10.797604161240269,"['MESP1', 'SCN5A']",0.710785318157976,0,0,2
29,GABA receptor Signaling WP4159,0.11176515396660434,4.927363184079602,10.797604161240269,"['AP2S1', 'AP2M1']",0.710785318157976,0,0,2
30,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.11967303826129187,inf,inf,['ELOB'],0.710785318157976,0,0,1
31,Homologous recombination WP186,0.11967303826129187,inf,inf,['POLD2'],0.710785318157976,0,0,1
32,Mitochondrial CII Assembly WP4920,0.11967303826129187,inf,inf,['SDHAF1'],0.710785318157976,0,0,1
33,Osteoclast Signaling WP12,0.11967303826129187,inf,inf,['ATP6V1G1'],0.710785318157976,0,0,1
34,Cell cycle WP179,0.13150389880707972,2.0590696117804552,4.177273188853607,"['CDKN2D', 'GADD45B', 'YWHAQ', 'ANAPC11', 'YWHAH']",0.7580812990055183,0,0,5
35,Endometrial cancer WP4155,0.13544406361082337,2.774326347305389,5.546423630407831,"['GADD45B', 'BAD', 'HRAS']",0.7584867562206108,0,0,3
36,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.1547694581259018,3.6940298507462686,6.892389738278282,"['BANF1', 'HRAS']",0.7778157382737628,0,0,2
37,Histone Modifications WP2369,0.1547694581259018,3.6940298507462686,6.892389738278282,"['SET', 'H3F3B']",0.7778157382737628,0,0,2
38,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.1547694581259018,3.6940298507462686,6.892389738278282,"['YWHAQ', 'NDRG1']",0.7778157382737628,0,0,2
39,Parkinson's disease pathway WP2371,0.1547694581259018,3.6940298507462686,6.892389738278282,"['CYCS', 'PARK7']",0.7778157382737628,0,0,2
40,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.19701825283682434,2.2176646706586824,3.6025051126695553,"['GADD45B', 'BAD', 'CYCS']",0.7985616779129109,0,0,3
41,Melanoma WP4685,0.19701825283682434,2.2176646706586824,3.6025051126695553,"['GADD45B', 'BAD', 'HRAS']",0.7985616779129109,0,0,3
42,Computational Model of Aerobic Glycolysis WP4629,0.20022241604393648,2.954029850746269,4.75104434339206,"['TPI1', 'PGK1']",0.7985616779129109,0,0,2
43,Cori Cycle WP1946,0.20022241604393648,2.954029850746269,4.75104434339206,"['TPI1', 'PGK1']",0.7985616779129109,0,0,2
44,DNA damage response WP707,0.20022241604393648,2.954029850746269,4.75104434339206,"['GADD45B', 'CYCS']",0.7985616779129109,0,0,2
45,miRNA regulation of DNA damage response WP1530,0.20022241604393648,2.954029850746269,4.75104434339206,"['GADD45B', 'CYCS']",0.7985616779129109,0,0,2
46,Oxidative Damage WP3941,0.20022241604393648,2.954029850746269,4.75104434339206,"['BAD', 'CYCS']",0.7985616779129109,0,0,2
47,Hepatitis B infection WP4666,0.21068391067489375,1.8490990990990992,2.8797801366602296,"['YWHAQ', 'BAD', 'CYCS', 'HRAS']",0.7985616779129109,0,0,4
48,Dual hijack model of Vif in HIV infection WP3300,0.22506195175923738,7.375,10.998924354746647,['ELOB'],0.7985616779129109,0,0,1
49,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.22506195175923738,7.375,10.998924354746647,['HRAS'],0.7985616779129109,0,0,1
50,Gastric Cancer Network 2 WP2363,0.22506195175923738,7.375,10.998924354746647,['S100A6'],0.7985616779129109,0,0,1
51,MTHFR deficiency WP4288,0.22506195175923738,7.375,10.998924354746647,['CYCS'],0.7985616779129109,0,0,1
52,Nanoparticle-mediated activation of receptor signaling WP2643,0.22506195175923738,7.375,10.998924354746647,['HRAS'],0.7985616779129109,0,0,1
53,Kit receptor signaling pathway WP304,0.24692672540947347,2.460696517412935,3.441686759366154,"['BAD', 'HRAS']",0.7985616779129109,0,0,2
54,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.24692672540947347,2.460696517412935,3.441686759366154,"['BAD', 'HRAS']",0.7985616779129109,0,0,2
55,IL-18 signaling pathway WP4754,0.2605460350068237,1.3775358733300347,1.8527522968934158,"['NRN1', 'BAD', 'TMSB4X', 'COX17', 'CYCS', 'NDUFC1', 'PTMS', 'ARF6']",0.7985616779129109,0,0,8
56,Senescence and Autophagy in Cancer WP615,0.26509205200385855,1.642308975642309,2.180457738011282,"['GABARAPL2', 'GABARAPL1', 'HRAS', 'GABARAP']",0.7985616779129109,0,0,4
57,Insulin Signaling WP481,0.26509205200385855,1.642308975642309,2.180457738011282,"['XBP1', 'HRAS', 'VAMP2', 'ARF6']",0.7985616779129109,0,0,4
58,Ras signaling WP4223,0.26509205200385855,1.642308975642309,2.180457738011282,"['GNG3', 'BAD', 'HRAS', 'ARF6']",0.7985616779129109,0,0,4
59,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.29393517715851397,2.108315565031983,2.5814131905440605,"['H3F3B', 'H2AFZ']",0.7985616779129109,0,0,2
60,TNF-alpha signaling pathway WP231,0.29820141690907365,1.7038231229847995,2.061602338475866,"['BAD', 'TXN', 'HRAS']",0.7985616779129109,0,0,3
61,Glycolysis and Gluconeogenesis WP534,0.29820141690907365,1.7038231229847995,2.061602338475866,"['TPI1', 'MPC2', 'PGK1']",0.7985616779129109,0,0,3
62,Apoptosis Modulation by HSP70 WP384,0.3178671339817318,3.6860119047619047,4.224618603455135,['CYCS'],0.7985616779129109,0,0,1
63,BDNF-TrkB Signaling WP3676,0.3178671339817318,3.6860119047619047,4.224618603455135,['HRAS'],0.7985616779129109,0,0,1
64,Type 2 papillary renal cell carcinoma WP4241,0.3178671339817318,3.6860119047619047,4.224618603455135,['ELOB'],0.7985616779129109,0,0,1
65,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3178671339817318,3.6860119047619047,4.224618603455135,['H3F3B'],0.7985616779129109,0,0,1
66,ERK Pathway in Huntington's Disease WP3853,0.3178671339817318,3.6860119047619047,4.224618603455135,['HRAS'],0.7985616779129109,0,0,1
67,Fatty acid beta-oxidation WP143,0.3178671339817318,3.6860119047619047,4.224618603455135,['TPI1'],0.7985616779129109,0,0,1
68,Genes targeted by miRNAs in adipocytes WP1992,0.3178671339817318,3.6860119047619047,4.224618603455135,['TMSB4X'],0.7985616779129109,0,0,1
69,Glutathione metabolism WP100,0.3178671339817318,3.6860119047619047,4.224618603455135,['GPX4'],0.7985616779129109,0,0,1
70,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3178671339817318,3.6860119047619047,4.224618603455135,['HRAS'],0.7985616779129109,0,0,1
71,Nanomaterial induced apoptosis WP2507,0.3178671339817318,3.6860119047619047,4.224618603455135,['CYCS'],0.7985616779129109,0,0,1
72,RalA downstream regulated genes WP2290,0.3178671339817318,3.6860119047619047,4.224618603455135,['HRAS'],0.7985616779129109,0,0,1
73,Rett syndrome causing genes WP4312,0.3178671339817318,3.6860119047619047,4.224618603455135,['TBL1X'],0.7985616779129109,0,0,1
74,Alzheimer's disease WP2059,0.33282366224147525,1.5814798973481607,1.7398532038093202,"['ATP5MD', 'BAD', 'CYCS']",0.7985616779129109,0,0,3
75,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.34050821221328076,1.8440298507462687,1.9866029283021815,"['BAD', 'HRAS']",0.7985616779129109,0,0,2
76,Cytosolic DNA-sensing pathway WP4655,0.34050821221328076,1.8440298507462687,1.9866029283021815,"['POLR2K', 'POLR2L']",0.7985616779129109,0,0,2
77,Leptin signaling pathway WP2034,0.34050821221328076,1.8440298507462687,1.9866029283021815,"['BAD', 'HRAS']",0.7985616779129109,0,0,2
78,NO/cGMP/PKG mediated Neuroprotection WP4008,0.34050821221328076,1.8440298507462687,1.9866029283021815,"['BAD', 'CYCS']",0.7985616779129109,0,0,2
79,Retinoblastoma gene in cancer WP2446,0.34050821221328076,1.8440298507462687,1.9866029283021815,"['H2AFZ', 'DCK']",0.7985616779129109,0,0,2
80,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.38607801146342047,1.6384742951907132,1.5593619200132123,"['HRAS', 'MYL12B']",0.7985616779129109,0,0,2
81,Ectoderm Differentiation WP2858,0.38607801146342047,1.6384742951907132,1.5593619200132123,"['TBL1X', 'LY6E']",0.7985616779129109,0,0,2
82,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.38607801146342047,1.6384742951907132,1.5593619200132123,"['BAD', 'HRAS']",0.7985616779129109,0,0,2
83,Modulators of TCR signaling and T cell activation WP5072,0.38607801146342047,1.6384742951907132,1.5593619200132123,"['NDUFB10', 'ELOB']",0.7985616779129109,0,0,2
84,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.38607801146342047,1.6384742951907132,1.5593619200132123,"['IFI27L2', 'HRAS']",0.7985616779129109,0,0,2
85,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3995871623564529,2.4563492063492065,2.253266504744282,['HRAS'],0.7985616779129109,0,0,1
86,Blood Clotting Cascade WP272,0.3995871623564529,2.4563492063492065,2.253266504744282,['F8A1'],0.7985616779129109,0,0,1
87,Tumor suppressor activity of SMARCB1 WP4204,0.3995871623564529,2.4563492063492065,2.253266504744282,['H3F3B'],0.7985616779129109,0,0,1
88,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.3995871623564529,2.4563492063492065,2.253266504744282,['PPIB'],0.7985616779129109,0,0,1
89,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3995871623564529,2.4563492063492065,2.253266504744282,['BAD'],0.7985616779129109,0,0,1
90,IL-7 signaling pathway WP205,0.3995871623564529,2.4563492063492065,2.253266504744282,['BAD'],0.7985616779129109,0,0,1
91,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.3995871623564529,2.4563492063492065,2.253266504744282,['SUPT4H1'],0.7985616779129109,0,0,1
92,Integrated Cancer Pathway WP1971,0.3995871623564529,2.4563492063492065,2.253266504744282,['BAD'],0.7985616779129109,0,0,1
93,MAPK Cascade WP422,0.3995871623564529,2.4563492063492065,2.253266504744282,['HRAS'],0.7985616779129109,0,0,1
94,Methionine De Novo and Salvage Pathway WP3580,0.3995871623564529,2.4563492063492065,2.253266504744282,['TXN'],0.7985616779129109,0,0,1
95,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.3995871623564529,2.4563492063492065,2.253266504744282,['ANAPC11'],0.7985616779129109,0,0,1
96,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3995871623564529,2.4563492063492065,2.253266504744282,['HRAS'],0.7985616779129109,0,0,1
97,Androgen receptor signaling pathway WP138,0.4016151043002019,1.3826721556886228,1.2613580230741412,"['BAG1', 'DSTN', 'PARK7']",0.7985616779129109,0,0,3
98,Small cell lung cancer WP4658,0.43021816948608976,1.4740298507462686,1.243289386563768,"['GADD45B', 'CYCS']",0.7985616779129109,0,0,2
99,Apoptosis WP254,0.43021816948608976,1.4740298507462686,1.243289386563768,"['BAD', 'CYCS']",0.7985616779129109,0,0,2
100,Complement system WP2806,0.43021816948608976,1.4740298507462686,1.243289386563768,"['RPS19', 'TXN']",0.7985616779129109,0,0,2
101,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.46384752121139045,1.179099099099099,0.905783219102523,"['YWHAQ', 'SCN5A', 'VAMP2', 'YWHAH']",0.7985616779129109,0,0,4
102,7q11.23 copy number variation syndrome WP4932,0.4682741629079374,1.2280439121756488,0.9317185573373648,"['VAMP2', 'ATP5F1E', 'ATP5MC1']",0.7985616779129109,0,0,3
103,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4715426320981074,1.8415178571428572,1.3843532465453965,['HRAS'],0.7985616779129109,0,0,1
104,Alpha 6 Beta 4 signaling pathway WP244,0.4715426320981074,1.8415178571428572,1.3843532465453965,['HRAS'],0.7985616779129109,0,0,1
105,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.4715426320981074,1.8415178571428572,1.3843532465453965,['HRAS'],0.7985616779129109,0,0,1
106,HIF1A and PPARG regulation of glycolysis WP2456,0.4715426320981074,1.8415178571428572,1.3843532465453965,['TPI1'],0.7985616779129109,0,0,1
107,IL-2 signaling pathway WP49,0.4715426320981074,1.8415178571428572,1.3843532465453965,['HRAS'],0.7985616779129109,0,0,1
108,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4715426320981074,1.8415178571428572,1.3843532465453965,['YWHAQ'],0.7985616779129109,0,0,1
109,miRNA regulation of prostate cancer signaling pathways WP3981,0.4715426320981074,1.8415178571428572,1.3843532465453965,['BAD'],0.7985616779129109,0,0,1
110,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.4715426320981074,1.8415178571428572,1.3843532465453965,['EIF1'],0.7985616779129109,0,0,1
111,Pathways affected in adenoid cystic carcinoma WP3651,0.4715426320981074,1.8415178571428572,1.3843532465453965,['HRAS'],0.7985616779129109,0,0,1
112,PDGFR-beta pathway WP3972,0.4715426320981074,1.8415178571428572,1.3843532465453965,['HRAS'],0.7985616779129109,0,0,1
113,DNA damage response (only ATM dependent) WP710,0.4726181359076411,1.339484396200814,1.003900075575589,"['BAD', 'HRAS']",0.7985616779129109,0,0,2
114,Integrated breast cancer pathway WP1984,0.4726181359076411,1.339484396200814,1.003900075575589,"['BAD', 'FAU']",0.7985616779129109,0,0,2
115,Pancreatic adenocarcinoma pathway WP4263,0.4726181359076411,1.339484396200814,1.003900075575589,"['GADD45B', 'BAD']",0.7985616779129109,0,0,2
116,Proteasome Degradation WP183,0.4726181359076411,1.339484396200814,1.003900075575589,"['H2AFZ', 'PSMB10']",0.7985616779129109,0,0,2
117,ErbB signaling pathway WP673,0.5130617220687917,1.227363184079602,0.8190920207382147,"['BAD', 'HRAS']",0.8359836020248663,0,0,2
118,Acute viral myocarditis WP4298,0.5348972296624622,1.4726190476190477,0.9213892350049013,['CYCS'],0.8359836020248663,0,0,1
119,Bladder cancer WP2828,0.5348972296624622,1.4726190476190477,0.9213892350049013,['HRAS'],0.8359836020248663,0,0,1
120,Unfolded protein response WP4925,0.5348972296624622,1.4726190476190477,0.9213892350049013,['XBP1'],0.8359836020248663,0,0,1
121,DNA Replication WP466,0.5348972296624622,1.4726190476190477,0.9213892350049013,['POLD2'],0.8359836020248663,0,0,1
122,Folate Metabolism WP176,0.5348972296624622,1.4726190476190477,0.9213892350049013,['GPX4'],0.8359836020248663,0,0,1
123,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5348972296624622,1.4726190476190477,0.9213892350049013,['PIN1'],0.8359836020248663,0,0,1
124,One-carbon metabolism and related pathways WP3940,0.5348972296624622,1.4726190476190477,0.9213892350049013,['GPX4'],0.8359836020248663,0,0,1
125,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5514090699748873,1.132491389207807,0.674147584644763,"['TMSB4X', 'PFN2']",0.8359836020248663,0,0,2
126,Chemokine signaling pathway WP3929,0.5514090699748873,1.132491389207807,0.674147584644763,"['GNG3', 'HRAS']",0.8359836020248663,0,0,2
127,Prolactin Signaling Pathway WP2037,0.5514090699748873,1.132491389207807,0.674147584644763,"['PPIB', 'HRAS']",0.8359836020248663,0,0,2
128,Fragile X Syndrome  WP4549,0.587581566951852,1.0511727078891258,0.5589507914314282,"['AP2S1', 'AP2M1']",0.8359836020248663,0,0,2
129,Mesodermal commitment pathway WP2857,0.587581566951852,1.0511727078891258,0.5589507914314282,"['ARL4A', 'RPL38']",0.8359836020248663,0,0,2
130,Amyotrophic lateral sclerosis (ALS) WP2447,0.5906763251673949,1.226686507936508,0.6458346034722438,['BAD'],0.8359836020248663,0,0,1
131,Aryl Hydrocarbon Receptor Netpath WP2586,0.5906763251673949,1.226686507936508,0.6458346034722438,['HRAS'],0.8359836020248663,0,0,1
132,Vitamin D-sensitive calcium signaling in depression WP4698,0.5906763251673949,1.226686507936508,0.6458346034722438,['GPX4'],0.8359836020248663,0,0,1
133,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5906763251673949,1.226686507936508,0.6458346034722438,['CYCS'],0.8359836020248663,0,0,1
134,Galanin receptor pathway WP4970,0.5906763251673949,1.226686507936508,0.6458346034722438,['VAMP2'],0.8359836020248663,0,0,1
135,Glycolysis in senescence WP5049,0.5906763251673949,1.226686507936508,0.6458346034722438,['PGK1'],0.8359836020248663,0,0,1
136,Prostaglandin Synthesis and Regulation WP98,0.5906763251673949,1.226686507936508,0.6458346034722438,['S100A6'],0.8359836020248663,0,0,1
137,Focal Adhesion WP306,0.6176949921409685,0.959125227805259,0.46206863356170014,"['BAD', 'HRAS', 'MYL12B']",0.8359836020248663,0,0,3
138,Translation Factors WP107,0.6215492611733325,0.9806965174129353,0.46636052920750404,"['EEF1B2', 'EIF1']",0.8359836020248663,0,0,2
139,G Protein Signaling Pathways WP35,0.6215492611733325,0.9806965174129353,0.46636052920750404,"['GNG3', 'HRAS']",0.8359836020248663,0,0,2
140,AGE/RAGE pathway WP2324,0.6397833688965814,1.0510204081632653,0.4694126687833336,['CYCS'],0.8359836020248663,0,0,1
141,CAMKK2  Pathway WP4874,0.6397833688965814,1.0510204081632653,0.4694126687833336,['FIS1'],0.8359836020248663,0,0,1
142,Zinc homeostasis WP3529,0.6397833688965814,1.0510204081632653,0.4694126687833336,['MT3'],0.8359836020248663,0,0,1
143,Ferroptosis WP4313,0.6397833688965814,1.0510204081632653,0.4694126687833336,['GPX4'],0.8359836020248663,0,0,1
144,IL-4 signaling pathway WP395,0.6397833688965814,1.0510204081632653,0.4694126687833336,['BAD'],0.8359836020248663,0,0,1
145,IL-6 signaling pathway WP364,0.6397833688965814,1.0510204081632653,0.4694126687833336,['BAD'],0.8359836020248663,0,0,1
146,Interleukin-11 Signaling Pathway WP2332,0.6397833688965814,1.0510204081632653,0.4694126687833336,['HRAS'],0.8359836020248663,0,0,1
147,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6397833688965814,1.0510204081632653,0.4694126687833336,['NDRG1'],0.8359836020248663,0,0,1
148,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6397833688965814,1.0510204081632653,0.4694126687833336,['NDUFA13'],0.8359836020248663,0,0,1
149,p38 MAPK Signaling Pathway WP400,0.6397833688965814,1.0510204081632653,0.4694126687833336,['HRAS'],0.8359836020248663,0,0,1
150,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6397833688965814,1.0510204081632653,0.4694126687833336,['PGK1'],0.8359836020248663,0,0,1
151,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6689140270940688,0.8816766467065869,0.35452194748410837,"['MARCKS', 'BAD', 'HRAS']",0.8419547956769621,0,0,3
152,Regulation of Actin Cytoskeleton WP51,0.682932757723641,0.8646180860403863,0.3297297811281574,"['TMSB4X', 'BRK1']",0.8419547956769621,0,0,2
153,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6830143495542703,0.9192708333333334,0.3504622701630716,['BEX3'],0.8419547956769621,0,0,1
154,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6830143495542703,0.9192708333333334,0.3504622701630716,['XBP1'],0.8419547956769621,0,0,1
155,Head and Neck Squamous Cell Carcinoma WP4674,0.6830143495542703,0.9192708333333334,0.3504622701630716,['HRAS'],0.8419547956769621,0,0,1
156,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6830143495542703,0.9192708333333334,0.3504622701630716,['HRAS'],0.8419547956769621,0,0,1
157,PDGF Pathway WP2526,0.6830143495542703,0.9192708333333334,0.3504622701630716,['HRAS'],0.8419547956769621,0,0,1
158,Photodynamic therapy-induced unfolded protein response WP3613,0.6830143495542703,0.9192708333333334,0.3504622701630716,['XBP1'],0.8419547956769621,0,0,1
159,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6830143495542703,0.9192708333333334,0.3504622701630716,['YWHAQ'],0.8419547956769621,0,0,1
160,Apoptosis Modulation and Signaling WP1772,0.7104464974762154,0.8162520729684909,0.2790452698024283,"['BAD', 'CYCS']",0.8565444022918126,0,0,2
161,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7210705427456585,0.8167989417989417,0.2671082065646812,['HRAS'],0.8565444022918126,0,0,1
162,TGF-beta Receptor Signaling WP560,0.7210705427456585,0.8167989417989417,0.2671082065646812,['HRAS'],0.8565444022918126,0,0,1
163,Genotoxicity pathway WP4286,0.7210705427456585,0.8167989417989417,0.2671082065646812,['RPS27'],0.8565444022918126,0,0,1
164,Hippo-Merlin Signaling Dysregulation WP4541,0.7210705427456585,0.8167989417989417,0.2671082065646812,['HRAS'],0.8565444022918126,0,0,1
165,Integrin-mediated Cell Adhesion WP185,0.7210705427456585,0.8167989417989417,0.2671082065646812,['HRAS'],0.8565444022918126,0,0,1
166,Pathways in clear cell renal cell carcinoma WP4018,0.7359382916348705,0.7729772191673213,0.23700177733635946,"['TPI1', 'PGK1']",0.8689391877134616,0,0,2
167,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7545697508970802,0.7348214285714286,0.20693126845563292,['HRAS'],0.8705340415505423,0,0,1
168,Thermogenesis WP4321,0.7545697508970802,0.7348214285714286,0.20693126845563292,['HRAS'],0.8705340415505423,0,0,1
169,Glucocorticoid Receptor Pathway WP2880,0.7545697508970802,0.7348214285714286,0.20693126845563292,['GADD45B'],0.8705340415505423,0,0,1
170,Breast cancer pathway WP4262,0.7594965362507282,0.7340298507462687,0.20193125778697962,"['GADD45B', 'HRAS']",0.8705340415505423,0,0,2
171,Gastrin signaling pathway WP4659,0.7594965362507282,0.7340298507462687,0.20193125778697962,"['BAD', 'HRAS']",0.8705340415505423,0,0,2
172,G1 to S cell cycle control WP45,0.7840562127789964,0.6677489177489178,0.16244632497640055,['CDKN2D'],0.8882949000270711,0,0,1
173,Glioblastoma signaling pathways WP2261,0.7840562127789964,0.6677489177489178,0.16244632497640055,['HRAS'],0.8882949000270711,0,0,1
174,ESC Pluripotency Pathways WP3931,0.8100093399143189,0.6118551587301587,0.12892369495007433,['HRAS'],0.9072104607040372,0,0,1
175,Oncostatin M Signaling Pathway WP2374,0.8100093399143189,0.6118551587301587,0.12892369495007433,['HRAS'],0.9072104607040372,0,0,1
176,T-cell receptor (TCR) signaling pathway WP69,0.8328514183033485,0.5645604395604396,0.10325811687732439,['HRAS'],0.9121392295485572,0,0,1
177,B Cell Receptor Signaling Pathway WP23,0.8328514183033485,0.5645604395604396,0.10325811687732439,['HRAS'],0.9121392295485572,0,0,1
178,Vitamin D Receptor Pathway WP2877,0.8363748350790885,0.6106965174129353,0.1091182760456349,"['CDKN2D', 'S100A6']",0.9121392295485572,0,0,2
179,Calcium Regulation in the Cardiac Cell WP536,0.8376788842792873,0.6459140542444523,0.11440458466875664,"['GNG3', 'YWHAQ', 'YWHAH']",0.9121392295485572,0,0,3
180,Ciliary landscape WP4352,0.8376788842792873,0.6459140542444523,0.11440458466875664,"['COX6C', 'DCAF11', 'LSM4']",0.9121392295485572,0,0,3
181,Myometrial relaxation and contraction pathways WP289,0.8508706744168306,0.6272027373823781,0.10129018818388306,"['GNG3', 'YWHAQ', 'YWHAH']",0.9174547908213273,0,0,3
182,Proximal tubule transport WP4917,0.8529543970283562,0.5240221088435374,0.08334529446138045,['ATP6V1G1'],0.9174547908213273,0,0,1
183,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8631211708414518,0.6095309381237525,0.08972307064495716,"['GNG3', 'BAD', 'HRAS']",0.9174547908213273,0,0,3
184,22q11.2 copy number variation syndrome WP4657,0.87064587292228,0.4888888888888889,0.06772086937925288,['MRPL40'],0.9174547908213273,0,0,1
185,Exercise-induced Circadian Regulation WP410,0.87064587292228,0.4888888888888889,0.06772086937925288,['DNAJA1'],0.9174547908213273,0,0,1
186,Pathogenic Escherichia coli infection WP2272,0.87064587292228,0.4888888888888889,0.06772086937925288,['YWHAQ'],0.9174547908213273,0,0,1
187,PI3K-Akt signaling pathway WP4172,0.8849996050868751,0.5769776236999685,0.0704882486079911,"['GNG3', 'BAD', 'HRAS']",0.9275931689680617,0,0,3
188,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8999139647978837,0.43102240896358546,0.04545394868254648,['HRAS'],0.9332441116422496,0,0,1
189,Metabolic reprogramming in colon cancer WP4290,0.8999139647978837,0.43102240896358546,0.04545394868254648,['PGK1'],0.9332441116422496,0,0,1
190,"GPCRs, Class A Rhodopsin-like WP455",0.9106809251128914,0.487363184079602,0.04559901047550975,"['GPR22', 'OR6A2']",0.9394392701164566,0,0,2
191,Metapathway biotransformation Phase I and II WP702,0.9225748041395203,0.38533834586466165,0.031053191091445474,['GPX4'],0.9467259770227539,0,0,1
192,Adipogenesis WP236,0.9536929358905559,0.31780538302277433,0.01506827489712194,['GADD45B'],0.9735615387216091,0,0,1
193,NRF2 pathway WP2884,0.9756705693629798,0.26052295918367346,0.006416753674965462,['TXN'],0.9908364331354614,0,0,1
194,Circadian rhythm related genes WP3594,0.990138425987376,0.20782312925170068,0.0020596355695158795,['RPS27A'],0.9923842273205035,0,0,1
195,Nuclear Receptors Meta-Pathway WP2882,0.9908979994017575,0.2842259291776412,0.0025988700602169387,"['GADD45B', 'TXN']",0.9923842273205035,0,0,2
196,MAPK Signaling Pathway WP382,0.9923842273205035,0.19642857142857142,0.0015016808637013013,['HRAS'],0.9923842273205035,0,0,1
